SmarTrend(R) News Watch: Teva Stops Shipments on Generic Birth Control Pending Infringement Case
Tue. July 07, 2009; Posted: 03:13 PM
Jul 07, 2009 (SmarTrend(R) News Watch via COMTEX) --
TEVA |
Quote |
Chart |
News |
PowerRating -- Teva Pharmaceutical Industries (NASDAQ:TEVA) said Tuesday that it has agreed to halt shipments of generic versions of Johnson & Johnson's (NYSE:JNJ) Ortho Tri-Cyclen Lo birth control pill. Shipments of the drugs will be suspended pending a preliminary injunction hearing in the patent infringement case with Johnson & Johnson scheduled to begin on July 15,2009. Teva Pharmaceutical Industries is a leading generic pharmaceutical company based in Israel, with 80% of sales from North America and Europe.
Write to Chip Brian at cbrian@tradethetrend.com
---------------------------------------------------------------------------------------------
SmarTrend analyzes over 5,000 securities simultaneously throughout the trading day and provides its subscribers with trend change alerts in real time. To get a free trial of our trading calls and maximize your trading results, please visit http://www.TradeTheTrend.com.
Get exclusive, actionable insight into how the market is expected to trend prior to market open with our free morning newsletter. Sign up at: http://www.TradeTheTrend.com/signup.html
For full details on Johnson & Johnson (JNJ)
click here. Johnson & Johnson (JNJ) has Short Term PowerRatings of 5. Details on Johnson & Johnson (JNJ) Short Term PowerRatings is available at
This Link.
More News:
Market Updates |
Stock Alerts |
All Trading News |
Stock Index